Muscle Function Recovery Following Botulinum Toxin Type A Facial Injections: A Case Managed With Photobiomodulation Therapy PBMT for BoNT-A recovery
Journal of Lasers in Medical Sciences,
Vol. 13 (2022),
10 January 2022
,
Page e54
Abstract
Background: Aesthetic applications of Botulinum toxin type A (BoNT-A) may lead to some complications or unwanted muscle paralysis.
Case Report: Given that the BoNT-A effects may last several months and there is no medical intervention to accelerate muscle function recovery so far, the present study aims at reporting a clinical case in which movement disorder of the mimic muscles resulting from BoNT-A injections was managed with daily sessions of photobiomodulation therapy (PBMT). It was noted a fast improvement in both facial asymmetry and muscle function within a few weeks. After nine weeks, almost complete recovery was achieved.
Conclusion: According to the current case, PMBT seems to be an effective intervention to accelerate muscle function recovery following BoNT-A use.
Doi:10.34172/jlms.2022.54- Botulinum Toxin A
- Low-Level Light Therapy
- Facial Muscles
How to Cite
References
2. Shackleton T, Ram S, Black M, Ryder J, Clark GT, Enciso R. The efficacy of botulinum toxin for the treatment of trigeminal and postherpetic neuralgia: a systematic review with meta-analyses. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;122(1):61–71.
3. Nestor MS, Han H, Gade A, Fischer D, Saban Y, Polselli R. Botulinum toxin–induced blepharoptosis: Anatomy, etiology, prevention, and therapeutic options. J Cosmet Dermatol. 2021;20(10):3133–46.
4. Majlesi G. GaAs Laser Treatment of Bilateral Eyelid Ptosis Due to Complication of Botulinum Toxin Type A Injection. Photomed Laser Surg. 2008;26(5):507–9.
5. Pena MA, Alam M, Yoo SS. Complications With the Use of Botulinum Toxin Type A for Cosmetic Applications and Hyperhidrosis. Semin Cutan Med Surg. 2007;26(1):29–33.
6. Steinsapir KD, Groth MJ, Boxrud CA. Persistence of Upper Blepharoptosis After Cosmetic Botulinum Toxin Type A. Dermatologic Surg. 2015;41(7):833–40.
7. Lee KC, Pascal AB, Halepas S, Koch A. What Are the Most Commonly Reported Complications With Cosmetic Botulinum Toxin Type A Treatments? J Oral Maxillofac Surg. 2020;78(7):1190.e1-1190.e9.
8. Flynn TC. Botulinum Toxin. Am J Clin Dermatol. 2010;11(3):183–99.
9. Semchyshyn NL, Suzanne KL. Does Laser Inactivate Botulinum Toxin? Dermatologic Surg. 2006 Mar 21;31(4):399–404.
10. Rochkind S, Geuna S, Shainberg A. Chapter 25 Phototherapy in Peripheral Nerve Injury. Int Rev Neurobiol. 2009;87:445–64.
- Abstract Viewed: 475 times
- PDF Downloaded: 439 times